Bolt Biotherapeutics, Inc. (BOLT) Net margin 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) net profit margin by fiscal year — reported net income divided by reported revenue.
-433.7%FY2025 · since FY2020: -26289.2% → -433.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -433.7% | +387.0 pp |
| FY2024 | -820.8% | +57.8 pp |
| FY2023 | -878.6% | +659.2 pp |
| FY2022 | -1537.8% | +6286.9 pp |
| FY2021 | -7824.7% | +18464.5 pp |
| FY2020 | -26289.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice